Publikationen in Zusammenarbeit mit Forschern von Universitat Pompeu Fabra (23)

2023

  1. Apoptotic cell death in disease—Current understanding of the NCCD 2023

    Cell Death and Differentiation, Vol. 30, Núm. 5, pp. 1097-1154

2021

  1. A proteomic approach for systematic mapping of substrates of human deubiquitinating enzymes

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome

    Neurobiology of Disease, Vol. 127, pp. 210-222

  2. Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Absence of Tangentially Migrating Glutamatergic Neurons in the Developing Avian Brain

    Cell Reports, Vol. 22, Núm. 1, pp. 96-109

  2. Role of the endocannabinoid system in drug addiction

    Biochemical Pharmacology, Vol. 157, pp. 108-121

2017

  1. CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal

    Biological Psychiatry, Vol. 81, Núm. 7, pp. 625-634

2016

  1. Differential control of cocaine self-administration by GABAergic and glutamatergic CB1 cannabinoid receptors

    Neuropsychopharmacology, Vol. 41, Núm. 9, pp. 2192-2205

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Possible therapeutic doses of cannabinoid type 1 receptor antagonist reverses key alterations in fragile X syndrome mouse model

    Genes, Vol. 7, Núm. 9

  4. Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome

    Molecular Brain, Vol. 9, Núm. 1

2013

  1. A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior

    Neuropsychopharmacology, Vol. 38, Núm. 9, pp. 1724-1736

  2. An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure

    Neuroscience Letters, Vol. 557, Núm. PB, pp. 101-106

  3. Targeting the endocannabinoid system in the treatment of fragile X syndrome

    Nature Medicine, Vol. 19, Núm. 5, pp. 603-607

2012

  1. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal

    Biological Psychiatry, Vol. 71, Núm. 3, pp. 214-223

  2. Influence of δ-opioid receptors in the behavioral effects of nicotine

    Neuropsychopharmacology, Vol. 37, Núm. 10, pp. 2332-2344

  3. The hypocretin/orexin system: Implications for drug reward and relapse

    Molecular Neurobiology, Vol. 45, Núm. 3, pp. 424-439

2011

  1. Deletion of the δ opioid receptor gene impairs place conditioning but preserves morphine reinforcement

    Biological Psychiatry, Vol. 69, Núm. 7, pp. 700-703

2010

  1. Effects of repeated MDMA administration on the motivation for palatable food and extinction of operant responding in mice

    Psychopharmacology, Vol. 208, Núm. 4, pp. 563-573